FCA CORP /TX

Position in LLY — ELI LILLY & Co

CIK 1166402 HOUSTON, TX

Position in LLY

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$436,592

+$105,475 QoQ

Shares Held

364

+1.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#3,860

of 4,604 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

FCA CORP /TX holds $16,215,017 across 6 Drug Manufacturers - General names. LLY ranks #6 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AMGN	Amgen Inc	16,245	$5,882,639
2	JNJ	Johnson & Johnson	19,411	$4,929,811
3	NVS	Novartis AG	23,419	$3,670,225
4	AZN	Astrazeneca PLC	3,750	$711,075
5	MRK	Merck & Co., Inc.	4,550	$584,675
6	LLY	ELI LILLY & Co This page	364	$436,592

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$436,592	364	+1.1%	Shares	Sole	2026-08-11
2026-03-31	$331,117	360	-4.0%	Shares	Sole	2026-05-14
2025-12-31	$403,005	375	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.